Great profile on Fibrotech, Certa and OccuRx CEO Darren Kelly
by Uniseed01 | Nov 28, 2019 | Latest News
In conversation with Darren Kelly, CEO of Certa Therapeutics and OccuRx Uniseed Investee Companies by Amirah Al Idrus, Editor at FierceBiotech.Recent Posts
- Uniseed investee Morse Micro, Australia’s largest semiconductor maker, today announced $140M in Series B funding
- Uniseed investee company Occurx receives $16m cash injection to progress first-in-class therapy for inflammation and fibrosis
- $1 Billion Raised by Uniseed-supported start-ups
- Uniseed invests in Bioscout’s Real-Time Airborne Disease Detection for Crops
- ENA Respiratory Selected for the BLUE KNIGHT™ Program to Accelerate Development of Pan-Antiviral Nasal Spray
Archives
- September 2022
- August 2022
- June 2022
- May 2022
- March 2022
- February 2022
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- February 2021
- December 2020
- November 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- January 2020
- December 2019
- November 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- February 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- November 2017
- October 2017
- September 2017
- July 2017
- June 2017
- May 2017
- March 2017
- February 2017
- September 2016
- April 2016
- December 2015
- September 2015
- July 2015
- June 2015
- May 2015
- March 2015
- February 2015
- October 2014
- September 2014
- August 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
Recent Comments